Browsing by Author "Oguz, D."
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
Item Estimated Plasma Volume as A Determinant of Heart Failure Hospitalization: TREAT-HF Data(2016) Sari, I.; Kaya, H.; Acar, G.; Cavusoglu, Y.; Demir, M.; Gungor, H.; Oguz, D.; Bekar, L.; Sahin, A. A.; Yilmaz, M. B.Item Heart Failure Awareness in Improved in Turkish HFREF Patients(2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Oguz, D.; Acar, G.; Celik, A.; Ege, M.Item Hemoglobin Bun Ratio Predicts Cardiovascular Mortality in Patients with Heart Failure(2014) Yucel, H.; Beton, Osman; Ekmekci, A.; Oguz, D.; Gunes, H.; Eren, M.; Uslu, A. U.; Yilmaz, M. B.Item Influence of Influenza Vaccination on Recurrent Hospitalization in Patients with Heart Failure(2017) Kaya, H.; Beton, O.; Acar, G.; Temizhan, A.; Cavusoglu, Y.; Guray, U.; Zoghi, M.; Ural, D.; Ekmekci, A.; Gungor, H.; Sari, I.; Oguz, D.; Yucel, H.; Zorlu, A.; Yilmaz, M. B.; 27460050The current study aimed to evaluate the influence of regular annual influenza vaccinations on cardiovascular (CV) death and heart failure-related hospitalizations (HFrH) in stable outpatients with heart failure with reduced ejection fraction. The Turkish research team-HF (TREAT-HF) is a network undertaking multicenter, observational cohort studies in HF. This study is a subgroup analysis of TREAT-HF outpatient cohorts who completed a questionnaire on influenza vaccination status and for whom follow-up data were available. A total of 656 patients with available follow-up data for CV death and HFrH including recurrent hospitalization were included in the study. Patients were classified into two groups: those who received regular influenza vaccination (40 %) and those who did not receive vaccination. During a mean follow-up of 15 +/- 6 months, 113 (18 %) patients had CV death and 471 (72 %) patients had at least one HFrH. The CV death rate was similar in both groups of patients (16 vs. 19 %, p = 0.37), whereas, HFrH and recurrent HFrH were significantly less frequently encountered in patients who received regular influenza vaccination than in those who did not receive vaccination (43 vs. 92 % and 16 vs. 66 %, p < 0.001, respectively). In a multivariate Cox proportional hazards model - in addition to a few clinical factors - vaccination status (HR = 0.30, 95 % CI = 0.17-0.51, p < 0.001) and graduation from university (HR = 0.35, 95 % CI = 0.17-0.72, p = 0.004) remained independently associated with the risk of recurrent HFrH. Regular influenza vaccination does not influence CV deaths; however, it decreases HFrH including recurrent episodes of HFrH in outpatients with heart failure with reduced ejection fraction.Item On demand pancreatic stenting in chronic pancreatitis might provide good palliation of pain(2019) Etik, D. O.; Parlak, E.; Oguz, D.; Oztas, E.; Kacar, S.; Onder, F. O.; Sasmaz, N.; Sahin, B.; 31566328Background and aim : Chronic pancreatitis (CP)-related pain is a considerable problem in gastroenterology practice that frequently requires several endoscopic interventions. We aimed to investigate the efficacy of pancreatic duct stenting performed on demand, instead of at defined intervals, for the management of the CP-related pain. Methods : This study is a retrospective evaluation of thirteen years of data. Sixty-seven patients with CP who suffered from intractable pain were enrolled in the study. Pancreatic stenting was performed mainly with single stents according to the diameter of the pancreatic duct and width of the stricture or, less frequently, with multiple stents to achieve stricture resolution. The subsequent endoscopic session was scheduled based on the patient's symptoms. Results : Overall, 65 of 67 patients underwent successful pancreatic cannulation (technical success rate 97%). Fifty-seven patients with a pancreatic stenting history were still undergoing follow-up. Of these patients, 26 patients still had pancreatic ductal stents; however, the stents were removed from 31 patients. Only 8 patients (25%) required furtherendoscopic or surgical intervention because of the re-emergence of pain after a median stent-free period of 17 months (3-127 months). One patient with a biliary stricture and one patient with a pancreatic mass underwent surgery. Pancreatic stents remained for a median length of 14 months (3-84 months). During the follow-up period, 55 of 65 patients became pain-free or had partial pain relief (clinical success rate 84%). Conclusions : On demand replacement of pancreatic stent is feasible in patients with CP and it might provide a good palliation of CP-related pain.Item Plasma Osmolality Predicts Mortality in Patients with Heart Failure with Reduced Ejection Fraction(2014) Yilmaz, Mehmet Birhan; Ekmekci, A.; Gunes, H.; Uslu, A. U.; Beton, O.; Yucel, H.; Oguz, D.; Eren, M.Item Presence of Accompanying Diabetes Mellitus Is Associated with Preserved Right Heart Functions Among HFREF outpatients(2015) Kaya, H. Hakki; Yagmur, B.; Acar, B.; Demir, M.; Eraslan, S.; Karauzum, K.; Oguz, D.; Acar, G.; Celik, A.; Yilmaz, M. B.Item Sodium Quartiles Predict Cardiovascular Mortality in Patients with Heart Failure(2014) Beton, Osman; Ekmekci, A.; Yucel, H.; Oguz, D.; Gunes, H.; Ugurlu, A. A.; Eren, M.; Yilmaz, M. B.